Paris-based startup Sonio, led by founder and CEO Cécile Brosset Dubois, is utilizing artificial intelligence (AI) to enhance fetal ultrasound readings.
Brosset Dubois aims to address disparities in prenatal care and improve healthcare access for women during pregnancy. Sonio’s AI-powered software automates ultrasound reporting, analyzes images for abnormalities, and aims to ensure safer outcomes for infants and expectant parents.
Cécile Brosset Dubois believes that AI can assist hospitals and clinicians in making more sophisticated assessments during ultrasounds. The AI technology is trained on a dataset of approximately 200,000 images, enabling it to quickly and accurately identify fetal abnormalities. Notably, Sonio’s AI is compatible with various sonography equipment from different manufacturers, eliminating the need for clinics to replace their existing machinery.
The significance of early detection of birth defects is highlighted, with one in 33 babies in the US being born with a birth defect. Sonio’s AI aims to expedite the diagnosis of rare pathologies and reduce errors in readings.
After raising $14 million in Series A funding and receiving FDA clearance, Sonio’s software is already being used in Europe, India, Brazil, and Nigeria. The company is set to enter the US market in 2024, aiming to further improve global access and quality of care for women and children through artificial and collective intelligence.
